Concepedia

Damon Young

DY

Statistics

Publications

10

Citations

258

H-Index

10

Active since

2005

Affiliations

Pfizer (United States)(Current)

Louis Stokes Cleveland VA Medical Center

Case Western Reserve University

University of Michigan

Damon Young is an author at Pfizer (United States) specializing in neuroscience, neuropharmacology, and life sciences.

Publications per year

2005–2020

10

Publications

10

Toward a Neuro-Cognitive Animal Model of the Cognitive Symptoms of Schizophrenia: Disruption of Cortical Cholinergic Neurotransmission Following Repeated Amphetamine Exposure in Attentional Task-Performing, but Not Non-Performing, Rats

Rouba Kozak, Vicente Martínez, Damon Young et al. · Neuropsychopharmacology · 2007 · 53 citations · Full text

, , +16

A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats

Ajeesh Koshy Cherian, Howard J. Gritton, David E. Johnson et al. · Neuropharmacology · 2014 · 51 citations

, , +12

D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects

Damon Young, Michael Popiolek, Patrick Trapa et al. · ACS Chemical Neuroscience · 2020 · 28 citations

, , +17

<i>In Vivo</i> Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer’s Disease and Schizophrenic Patients

Michael Popiolek, Yael Mandelblat-Cerf, Damon Young et al. · ACS Chemical Neuroscience · 2018 · 27 citations

, , +17

Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum

William M. Howe, Damon Young, George Bekheet et al. · Neurochemistry International · 2016 · 26 citations

, , +16

1–5 of 10